Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-370142
Filing Date
2014-10-14
Accepted
2014-10-14 06:16:09
Documents
3
Effectiveness Date
2014-10-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d796500ddefa14a.htm DEFA14A 60473
2 GRAPHIC g796500g60n68.jpg GRAPHIC 1424
3 GRAPHIC g796500img001.jpg GRAPHIC 5844
  Complete submission text file 0001193125-14-370142.txt   71734
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 141153636
SIC: 2835 In Vitro & In Vivo Diagnostic Substances